Commitments and Contingencies (Details)				3 Months Ended	12 Months Ended
	Apr. 01, 2018 USD ($) shares	Mar. 01, 2018 shares	Feb. 12, 2018 USD ($) $ / shares shares	Mar. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Oct. 16, 2019 USD ($)
Commitments and Contingencies (Details) [Line Items]
Damages claimed (in Dollars) | $						$ 18,000
Settlement claim (in Dollars) | $					$ 10,000
Number of shares issued				132,000
Number of shares issued, value (in Dollars) | $				$ 1,735,500
Corporate Advisory Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Number of shares issued	3,000,000
Number of shares issued at time of delivered	1,600,000
Description option to renew	Services commenced May 1, 2018 for a term of one year with an option to renew for an additional six months.
Monthly fee (in Dollars) | $	$ 6,500
Number of shares issued at time of delivered upon execution	1,400,000
Monthly installments shares	400,000
Accrued expenses (in Dollars) | $				110,500
Number of shares issued, value (in Dollars) | $				211,600
Carl W. Rausch [Member] | Employment Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Amount of signing bonus (in Dollars) | $				60,000
Annual salary (in Dollars) | $				224,000
Increase in annual salary upon relocating united states (in Dollars) | $				264,000
Increase in annual salary upon company listed on a national exchange (in Dollars) | $				$ 20,000
Carl W. Rausch [Member] | Stock Option [Member]
Commitments and Contingencies (Details) [Line Items]
Number of option granted		6,000,000
Description of reduction in exercise price		The First tranche of 2,000,000 will be exercisable at $0.10 per share and the second and third tranches of 2,000,000 will be exercisable at $0.15 per share.
Carl W. Rausch [Member] | Stock Option [Member] | Employment Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Number of option granted				6,000,000
Expiration period				5 years
Description of vesting				earned and vested in three equal tranches of 2,000,000 upon the Company raising $1,000,000 in financing, the Company raising $5,000,000 in financing and the Company entering into a significant corporate alliance for substantial marketing and selling of the Company’s product portfolio. The initial tranche shall be exercisable at $0.20 per share, the second tranche will be $0.40 per share and the third tranche shall be $0.60 per share, which such vesting is subject to Mr. Rausch’s continued employment as an executive with the Company as of the vesting date. In addition, as additional consideration for Mr. Rausch’s commitment to the Company, the stock options previously granted to Mr. Rausch shall be amended to extend the expiration date to the ten year anniversary of signing date and such options shall be considered fully vested.
Loraine Upham [Member]
Commitments and Contingencies (Details) [Line Items]
Annual salary (in Dollars) | $			$ 200,000
Description of accrual salary and bonus after achieving certain milestone			Ms. Upham’s salary shall accrue until the Company has raised a minimum of $1,250,000. Ms. Upham is eligible for bonuses as determined by the Board of Directors. These include a bonus of $20,000 is to be paid upon the Company successfully raising $1,250,000 through the sale of equity; an annual performance bonus based on milestones related to clinical progress, partnering and fund raising success to be established by the Board of Directors or the Compensation Committee, if in existence on an annual basis.
Loraine Upham [Member] | Employment Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Annual salary (in Dollars) | $			$ 188,716
Options term			5 years
Loraine Upham [Member] | 2011 Stock Incentive Plan [Member]
Commitments and Contingencies (Details) [Line Items]
Number of option granted			4,000,000
Vesting period			3 years
Loraine Upham [Member] | 2011 Stock Incentive Plan [Member] | Tranche One [Member]
Commitments and Contingencies (Details) [Line Items]
Number of option granted			1,333,334
Share price (in Dollars per share) | $ / shares			$ 0.06
Loraine Upham [Member] | 2011 Stock Incentive Plan [Member] | Tranche Two [Member]
Commitments and Contingencies (Details) [Line Items]
Number of option granted			1,333,333
Share price (in Dollars per share) | $ / shares			$ 0.10
Loraine Upham [Member] | 2011 Stock Incentive Plan [Member] | Tranche Three [Member]
Commitments and Contingencies (Details) [Line Items]
Number of option granted			1,333,333
Share price (in Dollars per share) | $ / shares			$ 0.20
Nanomix {Member]
Commitments and Contingencies (Details) [Line Items]
Preferred stock convert into common stock				35,029,160
Warrants exercisable				2,002,696
Options and restricted stock units exercisable				6,456,666
Outstanding shares of common stock upon closing of the merger, percentage				80.00%
CureDM Group Holdings, LLC [Member]
Commitments and Contingencies (Details) [Line Items]
Net proceeds equity financing (in Dollars) | $			$ 1,000,000
After closing date			180 days
CureDM Group Holdings, LLC [Member] | Contribution Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Outstanding securities			100.00%
Number of shares issued			47,741,140
Number of shares issued at time of delivered			25,000,000
Number of shares issued at time of milestone			22,741,140
Number of tranches for delivered | Tranches			4
Number of shares issued per tranche			5,685,285
Series C Convertible Preferred Stock [Member] | Nanomix {Member]
Commitments and Contingencies (Details) [Line Items]
Shares issued				1,000,000